- Home
- ENB vs PTHL Comparison
ENB vs PTHL Comparison
Compare ENB & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ENB | PTHL |
|---|---|---|
| Founded | 1949 | 1998 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.6B | 8.8M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | ENB | PTHL |
|---|---|---|
| Price | $47.49 | $0.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $63.00 | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 98.6K |
| Earning Date | 11-07-2025 | 01-01-0001 |
| Dividend Yield | ★ 5.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.84 | N/A |
| Revenue | ★ $46,115,630,085.00 | $448,196.00 |
| Revenue This Year | $15.33 | N/A |
| Revenue Next Year | $0.16 | N/A |
| P/E Ratio | $25.91 | ★ N/A |
| Revenue Growth | ★ 32.29 | N/A |
| 52 Week Low | $39.73 | $0.47 |
| 52 Week High | $50.54 | $32.00 |
Technical Indicators
Market Signals| Indicator | ENB | PTHL |
|---|---|---|
| Relative Strength Index (RSI) | 46.82 | 35.20 |
| Support Level | $46.98 | $0.50 |
| Resistance Level | $48.64 | $0.63 |
| Average True Range (ATR) | 0.71 | 0.04 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 26.06 | 19.46 |
Price Performance
Historical ComparisonAbout ENB Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the US and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates regulated natural gas utilities in the US and Canada, including Canada's largest natural gas distribution company. The firm has a small renewable energy portfolio primarily focused on onshore and offshore wind projects.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.